All Life Advance Immunology Sdn Bhd
Pioneering Provider for Regenerative Medicine with iPSC & CAR-T Therapies
Malaysian biotech firm specializing in commercialization of iPSC and CAR-T technologies for medical and aesthetic applications.
Opportunities
What we’re looking for?
Biopharmaceuticals
Estimated Budget
Project‑based Negotiation
Partnership Types
CDMO / CMO
Technology Licensing
Market Region
Asia Pacific
Company Overview
All Life Advance Immunology Sdn Bhd
Selangor, Malaysia
We are a regional biopharmaceutical enterprise leading scientific innovation, harnessing cutting-edge immunology and regenerative medicine technologies. At All Life, we pioneer cellular engineering, advancing iPSC reprogramming and CAR technologies to transform healthcare and deliver solutions benefiting both medical and general communities.
Company Highlights
1
Regional Biotech Presence
Positioned as a regional biopharma enterprise with research collaborations and a Malaysia operational base to support SEA development pathways.
2
GMP & Clinical Trial Capability
Operates clinical trial and GMP laboratory capabilities supporting translational research and therapeutic development.
3
Cutting-Edge Cellular R&D
Contact Info
Start the Conversation About Our Next Project
buyer name
job title
contact location
Contact Time Zone
UTC+08:00
(Asia / Kuala_Lumpur)
(Asia / Kuala_Lumpur)
Language
English
